Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
A.RatnerR
Heart (2019) 105(14):107886
GLP-1 agonism: Reduces appetite, slows gastric emptying, promotes satiety GIP agonism: Enhances insulin secretion, may reduce GLP-1-related nausea Glucagon agonism: Increases hepatic glucose output control, drives thermogenesis and energy expenditure Phase 2 clinical trial data published in 2023 showed subjects lost an average of 24.2% of body weight over 48 weeks making it arguably the most potent weight-loss compound currently known
Food and Drug Administration (2025) Compounding when drugs are on FDAs drug shortages list, U.S
Numeric data are expressed as the mean standard deviation (SD) and were analyzed by one-way ANOVA followed by LSD test
Lastly, Tirzepatide works at the hunger center of your brain to dampen your appetite
